...
首页> 外文期刊>Emerging Infectious Diseases >Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017
【24h】

Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017

机译:2017年,欧洲人类阪崎肠杆菌感染的多中心研究

获取原文

摘要

Cronobacter sakazakii has been documented as a cause of life-threating infections, predominantly in neonates. We conducted a multicenter study to assess the occurrence of C. sakazakii across Europe and the extent of clonality for outbreak detection. National coordinators representing 24 countries in Europe were requested to submit all human C. sakazakii isolates collected during 2017 to a study center in Austria. Testing at the center included species identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, subtyping by whole-genome sequencing (WGS), and determination of antimicrobial resistance. Eleven countries sent 77 isolates, including 36 isolates from 2017 and 41 historical isolates. Fifty-nine isolates were confirmed as C. sakazakii by WGS, highlighting the challenge of correctly identifying Cronobacter spp. WGS-based typing revealed high strain diversity, indicating absence of multinational outbreaks in 2017, but identified 4 previously unpublished historical outbreaks. WGS is the recommended method for accurate identification, typing, and detection of this pathogen.
机译:阪崎肠杆菌已被证明是威胁生命的感染的诱因,主要发生在新生儿中。我们进行了一项多中心研究,以评估欧洲范围内阪崎肠杆菌的发生情况以及爆发检测的克隆程度。代表欧洲24个国家的国家协调员被要求将2017年收集的所有阪崎肠杆菌人类分离株提交至奥地利的研究中心。在中心进行的测试包括通过基质辅助激光解吸/电离飞行时间质谱进行物种鉴定,通过全基因组测序(WGS)进行亚型分析以及确定抗菌素耐药性。 11个国家/地区发送了77株分离株,包括2017年的36株和41株历史分离株。 WGS确认有59个分离株为阪崎肠杆菌,这突出了正确鉴定Cronobacter spp的挑战。基于WGS的分型显示出高度的菌株多样性,表明2017年没有跨国爆发,但确定了4次以前未发表的历史爆发。建议使用WGS准确鉴定,分类和检测这种病原体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号